Matthew W. Emmens

Mr. Emmens has over 33 years of experience in the pharmaceutical industry, including Shire plc and businesses operated by Merck KGaA and Merck & Co. He has been a member of our Board of Directors since 2004.

Mr. Emmens is the Chief Executive Officer, Chairman of the Management Committee and a member of the Board of Directors of Shire Pharmaceuticals Group plc. Before joining Shire in 2003, Mr. Emmens served as president of Merck KGaA’s global prescription pharmaceuticals business in Darmstadt, Germany. In 1999, he joined Merck KGaA and established EMD Pharmaceuticals, its United States prescription pharmaceutical business. Mr. Emmens held the position of President and Chief Executive Officer at EMD Pharmaceuticals from 1999 to 2001. Earlier, Mr. Emmens held various positions, including Chief Executive Officer, at Astra Merck, Inc. as well as several positions at Merck & Co., Inc. Mr. Emmens received a B.S. degree in business management from Fairleigh Dickinson University.